Technology News and Research

RSS

Kyocera Kona offers flip phone with verbal translation enabling internet browsing for visually impaired

For the visually impaired, using a mobile device hasn't always been easy. Kyocera Kona from Sprint (NYSE: S) helps to solve that problem by providing an easy-to-use compact flip phone that is the first feature phone in the industry to offer verbal translation enabling Internet browsing.

7 Sep 2013

Researchers start Phase I clinical trial of implantable vaccine for treatment of melanoma

A cross-disciplinary team of scientists, engineers, and clinicians announced today that they have begun a Phase I clinical trial of an implantable vaccine to treat melanoma, the most lethal form of skin cancer.

7 Sep 2013

UW researchers receive $390,000 from 5 organizations dedicated to fostering technology

A product development team at the University of Washington (UW) will receive $390,000 from five organizations dedicated to fostering technology commercialization in Washington.

7 Sep 2013

Saban Research Institute hosted symposium on MUCMD at Children's Hospital Los Angeles

The Saban Research Institute recently hosted the 3rd annual Meaningful Use of Complex Medical Data (MUCMD) Symposium. Organized by Randall Wetzel, MD, chairman of the Department of Anesthesiology and Critical Care Medicine at Children's Hospital Los Angeles, MUCMD is a forum that fosters communication between physicians and "Big Data" experts in order to make use of the large amounts of medical data.

7 Sep 2013

Tactile Medical launches ambulatory device to heal venous leg ulcers

Tactile Medical (formerly Tactile Systems Technology Inc.), a Minneapolis-based developer and provider of home therapy devices, launched a first-of-its-kind ambulatory device for patients with chronic wounds. The ACTitouch Adaptive Compression Therapy system combines two proven therapies - intermittent and sustained compression - in one device to heal venous leg ulcers.

7 Sep 2013

Viamet initiates phase 2 clinical trial of antifungal agent VT-1161 for treatment of vulvovaginal candidiasis

Viamet Pharmaceuticals, Inc. announced today the initiation of the phase 2 clinical program for its antifungal agent VT-1161. The initial phase 2 study is designed to evaluate the safety and efficacy of VT-1161 in the treatment of vulvovaginal candidiasis (VVC) and is being conducted at leading clinical centers in the United States.

7 Sep 2013

New flexible microneedle patch allows drugs to deliver directly through skin

An assistant professor with the Virginia Tech - Wake Forest School of Biomedical Engineering has developed a flexible microneedle patch that allows drugs to be delivered directly and fully through the skin. The new patch can quicken drug delivery time while cutting waste, and can likely minimize side-effects in some cases, notable in vaccinations and cancer therapy.

7 Sep 2013

Human Urine Metabolome Study Envisions New Diagnostic Era

...

6 Sep 2013

New Sponge-Based Therapeutic Cancer Vaccine Begins Human Clinicals

...

6 Sep 2013

Enzymatics Acquires Archerdx For Up To $50M

...

6 Sep 2013

NIH Funds Minority Disease Susceptibility Studies

...

6 Sep 2013

New Type 1 Diabetes competitive landscape map released by TechAtlas Group

TechAtlas Group has announced the release of the latest Type 1 Diabetes competitive landscape map. This particular landscape highlights 71 international companies with over 140 drugs and devices currently on the market and in development.

6 Sep 2013

Sanofi To Commercialize Pozen Proton Pump Inhibitor/Aspirin Product

...

6 Sep 2013

Medivir, Daewoong Discontinue HBV Drug Development

...

6 Sep 2013

Muscle atrophy therapy: an interview with Dr. Levine, Clinical Associate Professor at Temple University School of Medicine

Atrophy is loss of muscle which can occur in response to either pain or trauma. When you stop using something like muscle it gets weaker.

6 Sep 2013

Trovagene, University of Southern California enter into clinical collaboration agreement

Trovagene, Inc., a developer of molecular diagnostics for cancer monitoring, today announced that the Company has entered into a clinical collaboration agreement with the University of Southern California to study genomic characterizations of metastatic colorectal cancers using Trovagene's proprietary cell-free DNA assays.

6 Sep 2013

Who's winning? Investors, lawyers, consultants are among those getting early boosts from the health law

Also in the news, Bloomberg reports that some employers may change their minds about offering employees insurance when tax advantages go up next year.

6 Sep 2013

New research initiative to focus on ultrasound therapy

The Focused Ultrasound Foundation and Philips have entered into an innovative public-private collaboration with The Institute of Cancer Research, London, and The Royal Marsden NHS Foundation Trust.

6 Sep 2013

More than 3,000 chemicals or "metabolites" can be detected in urine, say researchers

Researchers at the University of Alberta announced today that they have determined the chemical composition of human urine. The study, which took more than seven years and involved a team of nearly 20 researchers, has revealed that more than 3,000 chemicals or "metabolites" can be detected in urine.

6 Sep 2013

Researchers translate new technology to better study behaviors and cellular function to fruit flies

A team of researchers led by Charles D. Nichols, PhD, Associate Professor of Pharmacology at LSU Health Sciences Center New Orleans, has successfully translated a new technology to better study behaviors and cellular function to fruit flies.

6 Sep 2013

Technology News and Research

Kyocera Kona offers flip phone with verbal translation enabling internet browsing for visually impaired

Researchers start Phase I clinical trial of implantable vaccine for treatment of melanoma

UW researchers receive $390,000 from 5 organizations dedicated to fostering technology

Saban Research Institute hosted symposium on MUCMD at Children's Hospital Los Angeles

Tactile Medical launches ambulatory device to heal venous leg ulcers

Viamet initiates phase 2 clinical trial of antifungal agent VT-1161 for treatment of vulvovaginal candidiasis

New flexible microneedle patch allows drugs to deliver directly through skin

Human Urine Metabolome Study Envisions New Diagnostic Era

New Sponge-Based Therapeutic Cancer Vaccine Begins Human Clinicals

Enzymatics Acquires Archerdx For Up To $50M

NIH Funds Minority Disease Susceptibility Studies

New Type 1 Diabetes competitive landscape map released by TechAtlas Group

Sanofi To Commercialize Pozen Proton Pump Inhibitor/Aspirin Product

Medivir, Daewoong Discontinue HBV Drug Development

Muscle atrophy therapy: an interview with Dr. Levine, Clinical Associate Professor at Temple University School of Medicine

Trovagene, University of Southern California enter into clinical collaboration agreement

Who's winning? Investors, lawyers, consultants are among those getting early boosts from the health law

New research initiative to focus on ultrasound therapy

More than 3,000 chemicals or "metabolites" can be detected in urine, say researchers

Researchers translate new technology to better study behaviors and cellular function to fruit flies

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

Latest News